Stay updated on Safety of SAGE-718 in Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.

Latest updates to the Safety of SAGE-718 in Huntington's Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedOverall, the page updates its operating status notice and increases the version to v3.2.0, while removing the Huntington disease resource reference and the older v3.1.0 tag.SummaryDifference4%
- Check15 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedMinor update: version bumped from v3.0.1 to v3.0.2 and the 'Back to Top' link removed; core content and time-sensitive data remain unchanged.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the location as Washington D.C., District of Columbia, United States, 20007, and has added information regarding Huntington's disease and congenital diseases.SummaryDifference1%
- Check51 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
Stay in the know with updates to Safety of SAGE-718 in Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of SAGE-718 in Huntington's Disease Clinical Trial page.